Plasma suPAR is lowered by smoking cessation: a randomized controlled study

European Journal of Clinical Investigation
J Eugen-OlsenLars Tue Sørensen

Abstract

Soluble urokinase plasminogen activator receptor (suPAR) is a stable inflammatory biomarker. In patients, suPAR is a marker of disease presence, severity and prognosis. In the general population, suPAR is predictive of disease development, such as diabetes and cardiovascular disease and, in smokers, predictive of long-term lung cancer development. Whether smoking cessation impacts the suPAR level is unknown. Forty-eight smokers were randomized into three groups of 16: (i) continued to smoke 20 cigarettes per day, (ii) refrained from smoking and used transdermal nicotine patches and (iii) refrained from smoking and used placebo patches. Nonsmokers were included for comparison. suPAR and C-reactive protein (CRP) levels were measured by ELISA. At baseline, the suPAR level was significantly higher in the 48 smokers (median 3·2 ng mL, IQR (2·5-3·9)) than in 46 never smokers (1·9 ng/mL (1·7-2·2)). In smokers randomized to smoking cessation, suPAR levels after 4 weeks of stopping were decreased and no longer significantly different from the never smokers values. SuPAR decreased in both those who received a placebo as well as nicotine patch. Interestingly, those with the highest suPAR level at time of smoking were also those with the h...Continue Reading

References

May 13, 2006·Clinical Chemistry·Kristian KofoedJesper Eugen-Olsen
Dec 29, 2009·FEBS Letters·Francesco Blasi, Nicolai Sidenius
Jan 9, 2010·European Journal of Clinical Investigation·I SimeraD G Altman
Aug 1, 2007·Biomarkers in Medicine·David Conen, Paul M Ridker
Jan 18, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anne LangkildeJesper Eugen-Olsen
Mar 4, 2011·Journal of Internal Medicine·Jesper Eugen-Olsen
Mar 31, 2012·International Journal of Cardiology·Stig LyngbækJørgen Jeppesen
Aug 23, 2012·International Journal of Cardiology·Stig LyngbækJørgen Jeppesen
Oct 15, 2013·Journal of Critical Care·Katia DonadelloJean-Louis Vincent
Nov 21, 2013·Stroke; a Journal of Cerebral Circulation·Margaretha PerssonGunnar Engström
Mar 1, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Alexander KochFrank Tacke
Oct 3, 2014·Journal of the National Cancer Institute·Meredith S ShielsAnil K Chaturvedi
Jun 30, 2015·The Canadian Journal of Cardiology·Gethin W HodgesJørgen L Jeppesen

❮ Previous
Next ❯

Citations

Jan 14, 2017·Critical Reviews in Clinical Laboratory Sciences·S DesmedtM M Speeckaert
May 10, 2018·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Line Jee Hartmann RasmussenAvshalom Caspi
Sep 5, 2018·Postgraduate Medical Journal·Lamiaa HamieMazen Kurban
Jan 11, 2019·The British Journal of Nutrition·Peter B S TörnkvistJesper Eugen-Olsen
May 14, 2020·Scandinavian Cardiovascular Journal : SCJ·Gethin HodgesCasper N Bang
Apr 21, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Kjell E J HåkanssonLine J H Rasmussen
Aug 9, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Line Jee Hartmann RasmussenTerrie E Moffitt
Sep 24, 2020·Scientific Reports·Rafal N WlazelTomasz Kostka
Jun 21, 2020·Drug Discovery Today·Daniele D'AlonzoVincenzo Pavone
Dec 21, 2021·Frontiers in Immunology·Line Jee Hartmann RasmussenJesper Eugen-Olsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

© 2022 Meta ULC. All rights reserved